Connect with licensed Delaware telehealth providers offering semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro and Zepbound. Delivered to your door in 2-3 days. Starting at $75/mo.
Find GLP-1 ProvidersSkip the clinic. Complete a quick assessment, get approved by a licensed Delaware physician, and have your prescription delivered.
Find My Provider — from $75/moThree simple steps to get GLP-1 medication delivered to your door
Answer a few quick questions about your health and weight loss goals. Takes less than 5 minutes.
A licensed Delaware physician reviews your case and prescribes the right GLP-1 protocol within 24 hours.
Your GLP-1 medication arrives at your Edgemoor address within 2-3 business days with free discreet shipping.
Choose the GLP-1 option that fits your goals and budget
Affordable semaglutide prepared by licensed 503A/503B compounding pharmacies. Same active ingredient as Ozempic and Wegovy, available without insurance.
Dual GLP-1/GIP agonist compounded for affordability. Same molecule as Mounjaro and Zepbound, with the highest weight-loss potential of all GLP-1s.
FDA-approved semaglutide by Novo Nordisk. Ozempic for type 2 diabetes, Wegovy for chronic weight management. May be covered by insurance.
FDA-approved tirzepatide by Eli Lilly. Mounjaro for type 2 diabetes, Zepbound for weight management. The most effective GLP-1 medication available.
Clinical outcomes from GLP-1 patients at 12 months
Multiple payment and savings options available in Edgemoor
Many commercial plans cover GLP-1 therapy with prior authorization. Your local provider can verify benefits and submit paperwork on your behalf.
GLP-1 medications prescribed by a licensed provider are eligible HSA and FSA expenses. Pay with pre-tax dollars and save 20-35% on costs.
Medicare Part D covers Ozempic and Mounjaro for eligible beneficiaries with type 2 diabetes. Wegovy and Zepbound for weight loss are not yet covered.
Compounded GLP-1 medications offer the most affordable cash-pay option without insurance. Same active ingredients as brand-name at a fraction of the cost.
Novo Nordisk and Eli Lilly offer savings card programs for commercially insured patients on brand-name GLP-1 medications.
Real patients, real transformations with GLP-1 medication
Everything you need to know about GLP-1 medication in Edgemoor
Edgemoor residents now have direct access to the full spectrum of GLP-1 weight loss medications through licensed Delaware telehealth providers. With a population of approximately 6,349 residents and an adult obesity rate of 35.4%, Edgemoor is part of a nationwide shift toward accessible, evidence-based weight management. GLP-1 medications — including semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro, and Zepbound — are now available to qualifying adults throughout the Edgemoor metro area with no in-person visits required.
The two leading GLP-1 classes are semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (marketed as Mounjaro and Zepbound). Semaglutide activates one gut hormone receptor and produces 15-17% average body weight loss over 68 weeks. Tirzepatide activates two receptors (GLP-1 and GIP), producing up to 22.5% average weight loss at 72 weeks — the most powerful GLP-1 therapy approved today. Your Edgemoor provider will help you choose based on your health profile, weight loss goals, and budget.
Edgemoor patients can choose between brand-name GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) at $900-$1,350/month and compounded alternatives starting at $75/month for semaglutide and $149/month for tirzepatide. Compounded versions are prepared by 503A/503B licensed compounding pharmacies regulated by the Delaware State Board of Pharmacy and the FDA, and contain the same active pharmaceutical ingredients as brand-name products. Compounding provides Edgemoor patients with a cash-pay option during shortages and for those without insurance coverage.
To qualify for GLP-1 weight loss medication in Edgemoor, patients generally need a BMI of 30 or higher (obesity), or a BMI of 27 or higher (overweight) with at least one weight-related comorbidity such as type 2 diabetes, hypertension, high cholesterol, or obstructive sleep apnea. Your Edgemoor provider will evaluate your medical history, current medications, and weight loss goals during the online assessment to determine eligibility and match you with the appropriate GLP-1 medication and starting dose.
Insurance coverage for GLP-1 weight loss medication in Delaware varies significantly by plan. Many Blue Cross Blue Shield, UnitedHealthcare, Aetna, and Cigna plans cover Ozempic and Mounjaro for diabetic patients and Wegovy or Zepbound for weight management with prior authorization. Medicare Part D generally covers Ozempic and Mounjaro for diabetes but not Wegovy or Zepbound for weight loss. Our Edgemoor team can verify your benefits and submit prior authorization requests on your behalf to maximize coverage.
Common side effects of GLP-1 medications include nausea, diarrhea, decreased appetite, vomiting, constipation, and mild injection-site reactions — most resolve within the first 4 weeks as your body adjusts. Serious but rare risks include pancreatitis, gallbladder issues, and thyroid concerns. GLP-1 medications should not be used by patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Your Edgemoor physician will discuss the complete safety profile and start you on a low dose that titrates up gradually.
Starting GLP-1 weight loss treatment in Edgemoor takes just minutes. Complete a free 5-minute online assessment, undergo a virtual consultation with a licensed Delaware physician, and receive your prescription — all within 24 hours. Medication ships directly to your Edgemoor home in 2-3 business days via temperature-controlled packaging with all supplies (needles, syringes, alcohol wipes) included. No in-person visits, no insurance hassles, no waiting rooms — just a seamless path to proven weight loss results.
Telehealth available across Delaware and surrounding regions
GLP-1 telehealth available throughout Delaware
Join 470,000+ patients who chose telehealth GLP-1 treatment. Your licensed Delaware physician is ready to review your assessment within 24 hours.
Find My Provider — from $75/mo